MX2008011666A - Sintesis de compuestos que modulan la actividad de la trombopoyetina. - Google Patents

Sintesis de compuestos que modulan la actividad de la trombopoyetina.

Info

Publication number
MX2008011666A
MX2008011666A MX2008011666A MX2008011666A MX2008011666A MX 2008011666 A MX2008011666 A MX 2008011666A MX 2008011666 A MX2008011666 A MX 2008011666A MX 2008011666 A MX2008011666 A MX 2008011666A MX 2008011666 A MX2008011666 A MX 2008011666A
Authority
MX
Mexico
Prior art keywords
synthesis
modulating compounds
activity modulating
thrombopoietin activity
thrombopoietin
Prior art date
Application number
MX2008011666A
Other languages
English (en)
Inventor
Lin Zhi
Jackline E Dalgard
Dean Phillips
Original Assignee
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ligand Pharm Inc filed Critical Ligand Pharm Inc
Publication of MX2008011666A publication Critical patent/MX2008011666A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Se describen en la presente varios métodos para sintetizar compuestos que modulan la actividad de la trombopoyetina. También se describen intermediarios útiles para la preparación de estos compuestos.
MX2008011666A 2006-03-15 2007-03-14 Sintesis de compuestos que modulan la actividad de la trombopoyetina. MX2008011666A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78242606P 2006-03-15 2006-03-15
PCT/US2007/006547 WO2007106564A2 (en) 2006-03-15 2007-03-14 Synthesis of thrombopoietin activity modulating compounds

Publications (1)

Publication Number Publication Date
MX2008011666A true MX2008011666A (es) 2008-10-17

Family

ID=38308644

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008011666A MX2008011666A (es) 2006-03-15 2007-03-14 Sintesis de compuestos que modulan la actividad de la trombopoyetina.

Country Status (10)

Country Link
US (1) US20100063301A1 (es)
EP (1) EP2001845A2 (es)
JP (1) JP2009530297A (es)
KR (1) KR20090004953A (es)
CN (1) CN101437792A (es)
AU (1) AU2007225115A1 (es)
BR (1) BRPI0709286A2 (es)
CA (1) CA2646232A1 (es)
MX (1) MX2008011666A (es)
WO (1) WO2007106564A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005118551A2 (en) 2004-05-28 2005-12-15 Ligand Pharmaceuticals Inc. Thrombopoietin activity modulating compounds and methods
US20110129550A1 (en) 2007-02-16 2011-06-02 Connie Erickson-Miller Cancer treatment method
UY30915A1 (es) 2007-02-16 2008-09-02 Smithkline Beecham Corp Método de tratamiento de canceres
CA2709224C (en) 2007-10-09 2015-06-23 The Trustees Of The University Of Pennsylvania Thrombopoietin receptor agonist (tpora) kills acute human myeloid leukemia cells
US8476249B2 (en) 2009-05-07 2013-07-02 Glaxosmithkline Llc Method of treating thrombocytopenia
JP6072058B2 (ja) * 2011-11-14 2017-02-01 リガンド・ファーマシューティカルズ・インコーポレイテッド 顆粒球コロニー刺激因子受容体と結合する方法および組成物
US9962370B2 (en) 2013-03-15 2018-05-08 Ligand Pharmaceuticals Incorporated Methods of treatment associated with the granulocyte colony-stimulating factor receptor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148192A (en) * 1961-06-27 1964-09-08 Roussel Uclaf Halogenated 20alpha-yohimbane compounds
GB8816944D0 (en) * 1988-07-15 1988-08-17 Sobio Lab Compounds
WO2003011287A1 (en) * 2001-08-03 2003-02-13 Vertex Pharmaceuticals Incorporated Pyrazolon derivatives as inhibitors of gsk-3
JP4562523B2 (ja) * 2002-06-06 2010-10-13 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー トロンボポエチン疑似体
BRPI0511057A (pt) * 2004-05-12 2007-11-27 Bayer Cropscience Gmbh regulação de crescimento da planta

Also Published As

Publication number Publication date
US20100063301A1 (en) 2010-03-11
JP2009530297A (ja) 2009-08-27
EP2001845A2 (en) 2008-12-17
BRPI0709286A2 (pt) 2011-07-05
AU2007225115A1 (en) 2007-09-20
KR20090004953A (ko) 2009-01-12
CA2646232A1 (en) 2007-09-20
WO2007106564A3 (en) 2008-02-14
CN101437792A (zh) 2009-05-20
WO2007106564A2 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
MX2010003599A (es) Intermediarios y metodos para la sintesis de analogos de halicondrina b.
MY148253A (en) Azaadamantane derivatives and methods of use
TW200640924A (en) VEGF-R2 inhibitors and methods
NO20075643L (no) Fremgangsmater for fremstilling av 3-cyano-kinoliner og derved fremstilte mellomprodukter
MX342683B (es) Analogos de ciclopamina.
MX2007001127A (es) Moduladores de pirrolo-piridina cinasa.
MX2008011666A (es) Sintesis de compuestos que modulan la actividad de la trombopoyetina.
SG171617A1 (en) Therapeutic compounds
TW200626068A (en) Active compounds for seed treatment
UA94833C2 (en) Substituted bicyclolactams
MX2010009752A (es) Compuestos de oxadiazoantraceno para el tratamiento de diabetes.
EA201070256A1 (ru) Способ и промежуточные соединения для получения ингибиторов интегразы
EA201000883A1 (ru) Производные индолинона и способ их получения
AU2008303600A8 (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
WO2007138282A3 (en) Bi-aryl or aryl-heteroaryl substituted indoles
MY160392A (en) Triptolide prodrugs
WO2008041140A3 (en) Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents
WO2012015681A3 (en) Drug-ligand conjugates, synthesis thereof, and intermediates thereto
TW200728310A (en) Process for the preparation of ferri-succinylcasein
WO2008053334A3 (en) An improved process for preparing rosuvastatin calcium
TW200800986A (en) Tetrahydroquinolines, synthesis thereof, and intermediates thereto
TW200738713A (en) Diazepinoquinolines, synthesis thereof, and intermediates thereto
TN2009000536A1 (en) Novel herbicides
EA201170721A1 (ru) 3-аминоциклопентанкарбоксамиды в качестве модуляторов рецептора хемокина
MX2012006524A (es) Proceso para la sintesis de compuestos intermedios de utilidad para preparar compuestos sustituidos de indazol y azaindol.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal